Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study

• Main Authors: Yukako Yoshikane (Author), Yoshiaki Okuma (Author), Tatsuki Miyamoto (Author), Junichi Hashimoto (Author), Ryuji Fukazawa (Author), Taichi Kato (Author), Atsuhito Takeda (Author), Kenji Suda (Author), Takeji Matsushita (Author), Michiaki Hiroe (Author), Kyoko Imanaka-Yoshida (Author)
• Format: Book
• Published: BMC, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Tenascin-C (TN-C) is an extracellular matrix glycoprotein related to tissue inflammation. Our previous retrospective study conducted in 2016 revealed that the serum tenascin-C level was higher in patients with Kawasaki disease (KD) who were resistant to intravenous immunoglobulin...